Speaker Programs: Will the Recent Revisions on the PhRMA Code on Interactions with Health Care Professionals Change Physician Marketing by Pharmaceutical Companies?
This Bulletin is brought to you by AHLA’s Life Sciences Practice Group.
- August 27, 2021
- Virginia B. Evans , ThomsonReuters
On August 6, 2021, the Pharmaceutical Research and Manufacturers of America (PhRMA) released a revised version of the Code on Interactions with Health Care Professionals (HCPs), commonly referred to as the PhRMA Code. The PhRMA Code is a voluntary code of ethics that applies to pharmaceutical company interactions with U.S. health care professionals. It supports PhRMA's commitment that its members will adhere to the highest ethical standards and applicable legal requirements when dealing with HCPs, especially those in a position to prescribe drug products. Members of PhRMA (and some non-members) submit an annual certification that they have programs and policies in place that encourage compliance with the PhRMA Code. The U.S. Department of Health and Human Services (HHS), Office of Inspector General (OIG), considers drug manufacturers' compliance with the PhRMA Code as a positive step towards demonstrating good corporate citizenship and a commitment to obeying laws and regulations governing pharmaceutical marketing.
You must be logged in to access this content.